Suboxone Lawsuit Update October 2026: 2,022 Cases Pending, First Trial Set for March 2028

As of October 2026, 2,022 lawsuits alleging that Suboxone sublingual film caused severe tooth decay are consolidated in federal multidistrict litigation MDL 3092 in Ohio, up from 1,827 a month earlier. The court has set the first bellwether trial for March 2028, no settlement exists yet, and lawyers are still accepting new cases.

Key Facts: 2,022 Cases and Counting

  • 2,022 lawsuits were pending in MDL 3092 (U.S. District Court for the Northern District of Ohio) as of the Judicial Panel on Multidistrict Litigation's October 1, 2026 report — up from 1,827 in September.
  • The manufacturer told regulators that the cases involve roughly 26,307 plaintiffs as of July 24, 2026 — each filed lawsuit can represent many individuals.
  • The court plans to select four bellwether trial cases by June 11, 2027, with the first trial expected in March 2028.
  • The FDA issued a Drug Safety Communication in January 2022 linking buprenorphine medicines that dissolve in the mouth to dental problems; Indivior added a dental-injury warning to the label in June 2022.
  • No court-approved settlement has been announced, and the next status hearing is scheduled for October 27, 2026.

What Suboxone Is — and Why Teeth Got Involved

Suboxone is a prescription medicine used to treat opioid dependence. It combines buprenorphine, which eases withdrawal symptoms and cravings by acting on the brain's opioid receptors, with naloxone, which discourages misuse. The film version is placed under the tongue or against the cheek, where it dissolves slowly and delivers the medicine through the mouth's lining.

That delivery method is the heart of the litigation. Plaintiffs say the film's acidic formulation bathed their teeth in a low-pH environment day after day, year after year. They describe rampant cavities, cracked and crumbling teeth, root canals, extractions, and in some cases full-mouth reconstruction — damage their dentists traced to years of prescribed Suboxone use, even in patients with previously healthy teeth.

What the Lawsuits Allege

The lawsuits allege that Indivior, the manufacturer, knew for years that the film's acidity endangered teeth but failed to warn patients and doctors until long after thousands had already been harmed. According to the claims, patients prescribed the film before the June 2022 label change were never told to take protective steps as simple as rinsing the mouth after each dose — and prescribers received no direct "Dear Doctor" communication about the dental risk when the warning finally appeared.

In January 2022, the FDA's Drug Safety Communication warned that buprenorphine medicines that dissolve in the mouth — including Suboxone film — had been associated with dental problems such as tooth decay, cavities, oral infections, and tooth loss, and required updated prescribing information. Separately from the injury claims, Indivior's former parent company paid $1.4 billion in 2019 to resolve federal claims over Suboxone marketing practices — a documented enforcement action, not compensation for dental injuries.

Where the Litigation Stands in October 2026

The Suboxone MDL is past its earliest hurdles and firmly in the discovery phase. With the main motion-to-dismiss arguments largely resolved, the court is now managing how evidence is gathered across thousands of claims. For readers who prefer video explainers of how mass-tort timelines like this one work, the Problem Solved channel publishes plain-English walkthroughs of major money-and-law topics.

Recent court activity has been brisk. On September 21, 2026, the judge held a status hearing and entered an administrative order summarizing the proceedings and next steps, including allowing the parties to submit more information to resolve ongoing discovery disputes. On August 28, 2026, the judge issued a formal opinion clarifying which deposition transcripts and related materials the drug companies must disclose to plaintiffs — a ruling that confirmed plaintiffs' position on several contested documents. The October 27, 2026 status hearing is the next milestone to watch.

The case count keeps climbing. The jump from 1,827 pending lawsuits in September to 2,022 in October shows that new filings are still arriving steadily, and Indivior's own regulatory disclosures put the plaintiff population far higher than the filed-case count suggests.

The Road to Trial: Key Dates Ahead

A bellwether trial is an early test case selected from the group of lawsuits; its verdict shows both sides how juries respond to the evidence and often shapes later settlement negotiations. Under the current scheduling order, core discovery runs into 2027, four bellwether cases are to be selected by June 11, 2027, and the first trial is expected in March 2028.

That calendar matters for anyone considering a claim. Mass-tort settlements most often take shape after discovery progresses and bellwether trials give both sides a read on the litigation's value — a dynamic visible in other drug cases, from the Zantac litigation's October 2026 court status to how hernia mesh verdicts moved that litigation. No settlement discussions with concrete terms have been publicly reported in the Suboxone MDL so far.

Who Can Still File a Claim

Lawyers are still accepting Suboxone tooth-decay cases, and eligibility is evaluated individually. The strongest claims generally involve people who were prescribed Suboxone sublingual film and later developed serious dental injuries — severe decay, cracked or crumbling teeth, extractions, or reconstructive dental work — with a timeline that connects the damage to the period of film use.

The evidence that typically matters most is straightforward: pharmacy records or prescriptions proving Suboxone film use, dental records documenting the extent and timing of the damage, a timeline showing the injuries arose during or after the film use, and receipts for dental treatments or out-of-pocket costs. Plaintiffs prescribed before the June 2022 warning carry the core failure-to-warn theory, but each case is assessed on its own facts.

Deadlines: Why Waiting Is Risky

The March 2028 trial date does not pause your personal filing deadline. Each state's statute of limitations — the legal time limit for filing a lawsuit — runs on its own clock, and many states apply a "discovery rule," meaning the clock starts when you reasonably learned, or should have learned, that the drug caused your dental damage. Miss that window, and the claim is lost regardless of how strong the MDL becomes.

Because the rules differ by state, promptness is the only safe strategy. For example, one firm's October 2026 update notes that Alabama generally allows two years from discovering the damage. A qualified mass-tort attorney can evaluate your timeline in a free consultation — and if the long wait for trial creates financial pressure, it is worth understanding how pre-settlement lawsuit loans work, including their costs, before signing anything.

Who Benefits From This — and Who Does Not

Who benefits most from this guide:

People who were prescribed Suboxone sublingual film and later developed serious dental injuries How: the strongest claims involve severe decay, cracked or crumbling teeth, extractions, or reconstructive dental work, with a timeline connecting the damage to the period of film use

People prescribed before the June 2022 warning How: prescriptions from before the June 2022 label change carry the core failure-to-warn theory, though each case is assessed on its own facts

People who can produce pharmacy records, dental records, a timeline, and treatment receipts How: that evidence is what typically matters most: proof of film use, documentation of the extent and timing of the damage, and out-of-pocket costs

Who does not benefit:

Tablet-only users How: the MDL focuses on the sublingual film that dissolves under the tongue or against the cheek, and tablet-based claims are generally not part of this litigation

Anyone expecting a settlement payout now How: no court-approved settlement has been announced in MDL 3092 as of October 2026

Anyone who waits for the March 2028 trial before acting How: the trial date does not pause your personal filing deadline, and many states apply a discovery rule measured from when you reasonably learned the drug caused the damage

For how another drug-injury MDL is progressing, see our Zantac lawsuit status report.

Frequently Asked Questions

Has there been a Suboxone tooth-decay settlement?

No. As of October 2026, no court-approved settlement has been announced in MDL 3092. Settlement talks in pharmaceutical mass torts typically become meaningful only after discovery advances and bellwether trials set expectations.

Do the lawsuits cover Suboxone tablets, or only the film?

The MDL focuses on the sublingual film — the version that dissolves under the tongue or against the cheek and exposes teeth to prolonged acidity. Tablet-based claims are generally not part of this litigation.

I was prescribed Suboxone after the 2022 warning. Can I still file?

Each case is evaluated individually. The central failure-to-warn claims concern prescriptions from before the June 2022 label change, but other legal theories may apply to later use. An attorney can assess your specific timeline.

Will filing a claim affect my recovery or my prescription?

Filing a legal claim does not require stopping treatment, and you should never stop a prescribed medication without talking to your doctor first.

This article provides general information only and is not legal or medical advice. Mass-tort litigation involves unproven allegations; no manufacturer has been found liable in these cases. If you believe you were harmed, consult a qualified attorney about your rights and deadlines.

Who benefits from a Suboxone claim, and who does not?

People prescribed Suboxone sublingual film who later developed serious dental injuries benefit most, especially those prescribed before the June 2022 warning and those who can produce pharmacy records, dental records, a timeline, and receipts. Tablet-only users generally do not benefit, because the MDL focuses on the film, and neither does anyone expecting a settlement now, since no court-approved settlement has been announced in MDL 3092 as of October 2026.

How do I start a Suboxone claim?

Gather your pharmacy records or prescriptions proving Suboxone film use, dental records documenting the extent and timing of the damage, a timeline showing the injuries arose during or after film use, and receipts for dental treatments or out-of-pocket costs. Then consult a qualified mass-tort attorney promptly, since your state's statute of limitations runs on its own clock and the March 2028 trial date does not pause it.

Watch on YouTube

Problem Solved on YouTube